| # | Title | Journal | Year | Citations |
|---|
| 1 | The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension | Canadian Journal of Cardiology | 2015 | 431 |
| 2 | Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension | Canadian Journal of Cardiology | 2016 | 400 |
| 3 | Lamotrigine-Associated Rash: Risk/Benefit Considerations in Adults and Children | Epilepsia | 1999 | 310 |
| 4 | Alfentanil Mediated Activation of Epileptiform Activity in the Electrocorticogram During Resection of Epileptogenic Foci | Canadian Journal of Neurological Sciences | 1997 | 303 |
| 5 | Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults | Canadian Journal of Cardiology | 2017 | 269 |
| 6 | A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies | Movement Disorders | 2019 | 213 |
| 7 | Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis | JAMA Neurology | 2017 | 199 |
| 8 | Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal | Stroke | 2012 | 186 |
| 9 | The Treatment of Narcolepsy-Cataplexy with Nocturnal Gamma-Hydroxybutyrate | Canadian Journal of Neurological Sciences | 1979 | 172 |
| 10 | Living Beyond Our Physiological Means | Stroke | 2009 | 165 |
| 11 | Data Analytics from Enroll‐HD, a Global Clinical Research Platform for Huntington's Disease | Movement Disorders Clinical Practice | 2017 | 137 |
| 12 | MDS evidence‐based review of treatments for essential tremor | Movement Disorders | 2019 | 108 |
| 13 | Alpha‐synuclein in the appendiceal mucosa of neurologically intact subjects | Movement Disorders | 2014 | 107 |
| 14 | Aggressive multiple sclerosis: proposed definition and treatment algorithm | Nature Reviews Neurology | 2015 | 107 |
| 15 | The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics | Electroencephalography and Clinical Neurophysiology | 1983 | 99 |
| 16 | Comparison of the Psychosocial Effects of Epilepsy and Narcolepsy/Cataplexy: A Controlled Study | Epilepsia | 1984 | 96 |
| 17 | Pan-viral serology implicates enteroviruses in acute flaccid myelitis | Nature Medicine | 2019 | 93 |
| 18 | Excessive fragmentary myoclonus in NREM sleep: A report of 38 cases | Electroencephalography and Clinical Neurophysiology | 1985 | 84 |
| 19 | RELAXATION PROPHYLAXIS FOR CHILDHOOD MIGRAINE: A RANDOMIZED PLACEBO‐CONTROLLED TRIAL | Developmental Medicine and Child Neurology | 1988 | 81 |
| 20 | The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome | Genetics in Medicine | 2019 | 80 |
| 21 | Anakinra usage in febrile infection related epilepsy syndrome: an international cohort | Annals of Clinical and Translational Neurology | 2020 | 80 |
| 22 | Congenital Myotonic Dystrophy: Assisted Ventilation Duration and Outcome | Pediatrics | 2004 | 76 |
| 23 | Primary prevention of stroke: blood pressure, lipids, and heart failure | European Heart Journal | 2011 | 76 |
| 24 | Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation | JAMA Neurology | 2016 | 71 |
| 25 | Small Intracerebral Haemorrhages are Associated with Less Haematoma Expansion and Better Outcomes | International Journal of Stroke | 2011 | 68 |
| 26 | Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects | Movement Disorders | 2016 | 68 |
| 27 | Integrated systems of stroke care and reduction in 30-day mortality | Neurology | 2016 | 68 |
| 28 | Association of Statins and Statin Discontinuation With Poor Outcome and Survival After Intracerebral Hemorrhage | Stroke | 2012 | 67 |
| 29 | The Component Structure of the Human Event-Related Potentials | Progress in Brain Research | 1980 | 65 |
| 30 | Transducer-based evaluation of tremor | Movement Disorders | 2016 | 64 |
| 31 | Reproducibility of data-driven Parkinson's disease subtypes for clinical research | Parkinsonism and Related Disorders | 2018 | 63 |
| 32 | Childhood chronic inflammatory demyelinating polyradiculoneuropathy: Combined analysis of a large cohort and eleven published series | Neuromuscular Disorders | 2013 | 62 |
| 33 | Cerebrospinal Fluid Total Protein Reference Intervals Derived from 20 Years of Patient Data | Clinical Chemistry | 2017 | 61 |
| 34 | Complete ophthalmoplegia as a complication of acute corticosteroid‐ and pancuronium‐associated myopathy | Neurology | 1991 | 61 |
| 35 | Medical and Cognitive Outcome in Children with Traumatic Brain Injury | Canadian Journal of Neurological Sciences | 2004 | 59 |
| 36 | The time to and determinants of first fractures in boys with Duchenne muscular dystrophy | Osteoporosis International | 2017 | 59 |
| 37 | Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations | Journal of Parkinson's Disease | 2021 | 56 |
| 38 | Outcomes of Cognitively Impaired Not Demented at 2 Years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias | Dementia and Geriatric Cognitive Disorders | 2006 | 53 |
| 39 | Deflazacort for the treatment of Duchenne Dystrophy: A systematic review | BMC Neurology | 2003 | 50 |
| 40 | Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology | Neurobiology of Aging | 2015 | 50 |
| 41 | Fifteen Years of Clinical Trials in Huntington’s Disease: A Very Low Clinical Drug Development Success Rate | Journal of Huntington's Disease | 2017 | 50 |
| 42 | Intraparenchymal Epithelial (Enterogenous) Cyst of the Medulla Oblongata | Canadian Journal of Neurological Sciences | 1989 | 48 |
| 43 | Generic Substitution for Brand Name Antiepileptic Drugs: A Survey | Canadian Journal of Neurological Sciences | 2000 | 48 |
| 44 | A Randomized, Controlled Trial of Linopirdine in the Treatment of Alzheimer's Disease | Canadian Journal of Neurological Sciences | 1997 | 47 |
| 45 | Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy | Seizure: the Journal of the British Epilepsy Association | 2000 | 45 |
| 46 | Another face of placebo: The lessebo effect in Parkinson disease | Neurology | 2014 | 45 |
| 47 | Usage of the HINTS exam and neuroimaging in the assessment of peripheral vertigo in the emergency department | Journal of Otolaryngology - Head and Neck Surgery | 2018 | 45 |
| 48 | Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood | Neurology | 2015 | 44 |
| 49 | Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations | Movement Disorders | 2016 | 44 |
| 50 | A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1) | Pediatric Neurology | 2020 | 44 |
